41 Stock Overview
Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Biotechnology Assets, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.26 |
| 52 Week High | €0.39 |
| 52 Week Low | €0.21 |
| Beta | 1.27 |
| 1 Month Change | -6.91% |
| 3 Month Change | -21.17% |
| 1 Year Change | 0.19% |
| 3 Year Change | -61.62% |
| 5 Year Change | -82.14% |
| Change since IPO | -87.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| 41 | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | -3.8% | -4.9% | -1.5% |
| 1Y | 0.2% | -19.9% | 0.9% |
Return vs Industry: 041 exceeded the German Biotechs industry which returned -19.4% over the past year.
Return vs Market: 041 matched the German Market which returned -0.4% over the past year.
Price Volatility
| 41 volatility | |
|---|---|
| 41 Average Weekly Movement | 12.3% |
| Biotechs Industry Average Movement | 4.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 041's share price has been volatile over the past 3 months.
Volatility Over Time: 041's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1954 | 37 | Jaime Feced Rubio | www.biatgroup.com |
Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally. The company was founded in 1954 and is based in Cádiz, Spain.
Biotechnology Assets, S.A. Fundamentals Summary
| 41 fundamental statistics | |
|---|---|
| Market cap | €20.20m |
| Earnings (TTM) | €1.57m |
| Revenue (TTM) | €3.91m |
12.8x
P/E Ratio5.2x
P/S RatioIs 41 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 41 income statement (TTM) | |
|---|---|
| Revenue | €3.91m |
| Cost of Revenue | €450.59k |
| Gross Profit | €3.46m |
| Other Expenses | €1.88m |
| Earnings | €1.57m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.027 |
| Gross Margin | 88.47% |
| Net Profit Margin | 40.27% |
| Debt/Equity Ratio | 62.7% |
How did 41 perform over the long term?
See historical performance and comparison